Search Results - "Bayo, J. L."

Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer by Blancas, I., Olier, C., Conde, V., Bayo, J. L., Herrero, C., Zarcos-Pedrinaci, I., Carabantes, F., Baena-Cañada, J. M., Cruz, J., Ruiz-Borrego, M.

“…Goals of endocrine therapy for advanced breast cancer (ABC) include prolonging survival rates, maintaining the quality of life, and delaying the initiation of…”
Get full text

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice by Blancas, I., Fontanillas, M., Conde, V., Lao, J., Martínez, E., Sotelo, M. J., Jaen, A., Bayo, J. L., Carabantes, F., Illarramendi, J. J., Gordon, M. M., Cruz, J., García-Palomo, A., Mendiola, C., Pérez-Ruiz, E., Bofill, J. S., Baena-Cañada, J. M., Jáñez, N. M., Esquerdo, G., Ruiz-Borrego, M.

“…Introduction This study aimed to describe the efficacy of fulvestrant 500 mg in postmenopausal women with estrogen receptor (ER)-positive advanced/metastatic…”
Get full text

Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice by Blancas, I., Fontanillas, M., Conde, V., Lao, J., Martínez, E., Sotelo, M. J., Jaen, A., Bayo, J. L., Carabantes, F., Illarramendi, J. J., Gordon, M. M., Cruz, J., García-Palomo, A., Mendiola, C., Pérez-Ruiz, E., Bofill, J. S., Baena-Cañada, J. M., Jáñez, N. M., Esquerdo, G., Ruiz-Borrego, M.

“…A sentence under ‘Results’ heading in the Abstract section was published incorrectly. The correct sentence should read as follows:…”
Get full text

Design and Evaluation of a Solo-Resident Smart Home Testbed for Mobility Pattern Monitoring and Behavioural Assessment by Shirali, Mohsen, Bayo-Monton, Jose-Luis, Fernandez-Llatas, Carlos, Ghassemian, Mona, Traver Salcedo, Vicente

“…Aging population increase demands for solutions to help the solo-resident elderly live independently. Unobtrusive data collection in a smart home environment…”
Get full text

Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study by Ruíz-Borrego, Manuel, Guerrero-Zotano, Angel, Bermejo, Begoña, Ramos, Manuel, Cruz, Josefina, Baena-Cañada, Jose Manuel, Cirauqui, Beatriz, Rodríguez-Lescure, Álvaro, Alba, Emilio, Martínez-Jáñez, Noelia, Muñoz, Montserrat, Antolín, Silvia, Álvarez, Isabel, Del Barco, Sonia, Sevillano, Elena, Chacón, José Ignacio, Antón, Antonio, Escudero, María José, Ruiz, Victoria, Carrasco, Eva, Martín, Miguel

“…Purpose GEICAM/2006–10 compared anastrozole (A) versus fulvestrant plus anastrozole (A + F) to test the hypothesis of whether a complete oestrogen blockade is…”
Get full text

Enhancing medical evidence discovery through Interactive Pattern Recognition and process mining by Traver, V., Martinez-Romero, A., Bayo, J. L., Sala, P., Carvalho, P., Henriques, J., Ruano, M. G., Bianchi, A., Fernandez-Llatas, C.

“…Surrounded by heterogeneous clinical data, medical staff needs to take easily the right decisions at the point of care in real time supported by medical…”
Get full text

Design of a self-administered online food frequency questionnaire (FFQ) to assess dietary intake among university population by González Carrascosa, R, Bayo Montó, J L, Meneu Barreira, T, García Segovia, P, Martínez-Monzó, J

“…To introduce and describe a new tool called UPV-FFQ to evaluate dietary intake of the university population. The new tool consists principally in a…”
Get full text

First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis by Salvador, J., Jaen, A., Ciruelos, E. M., Codes, M., Gil, M., Murias, A., Galan, A., De la Haba, J. R., Jara, C., Bayo, J. L., Baena, J. M., Casal, J., Mel, J. R., Blancas, I., Gonzalez, E., Perez, D., Manso, L.

“…Abstract only…”
Get full text

Safety of long-term administration of capecitabine in metastatic breast cancer patients by Lomas, M., Salvador, J., Ruiz, M., Bayo, J. L.

“…Abstract only 10755 Background: To evaluate the effectiveness and tolerability of long -term treatment with capecitabine in metastatic breast cancer patients…”
Get full text

Design of a self-administered online food frequency questionnaire (FFQ) to assess dietary intake among university population Diseño de un cuestionario de frecuencia de consumo de alimentos autoadministrado online para evaluar la ingesta dietetica de la población universitaria by R. González Carrascosa, J. L. Bayo Montó, T. Meneu Barreira, P. García Segovia, J. Martínez-Monzó

“…Objective: To introduce and describe a new tool called UPV-FFQ to evaluate dietary intake of the university population. The new tool consists principally in a…”
Get full text

Clinical value of circulating epithelial tumor cells and circulating endothelial cells (CTCs/CECs) in patients with HER2-negative recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) as first-line therapy by Manso, L., Ciruelos, E. M., Codes, M., De la Haba, J. R., Galan, A., Baena, J. M., Jaen, A., Gil, M., Murias, A., Blancas, I., Gonzalez, E., Perez, D., Bayo, J. L., Mel, J. R., Garcia-Martinez, E., Cubedo, R., Salvador, J.

“…Abstract only…”
Get full text

Docetaxel (T) followed by capecitabine (X) as first-line chemotherapy in patients (pts) with metastatic breast cancer (MBC): Preliminary findings from a phase II study by Bayo, J. L., Lomas, M., Salvador, J., Ruiz, M., Moreno, A.

“…Abstract only 10692 Background: X and T are highly active single agents in MBC. The XT combination leads to superior overall survival (OS), time to progression…”
Get full text

Randomized open label phase II study of pegilated liposomal doxorubicine (PLD) four or six-week scheduled in metastatic breast cancer (MBC) patients (p) by Ruiz, M., Bayo, J. L., Moreno Nogueira, J. A., Dorta, J., Casas, A. M., Morales, M.

“…Abstract only 10751 Background: PLD has the advantage of delivering the active anthracycline directly to the tumour site, provide comparable efficacy to…”
Get full text

Docetaxel followed by capecitabine as first-line chemotherapy in metastatic breast cancer patients: Preliminary results by Bernabe Caro, R., Bayo, J. L., Salvador, J., Lomas, M., Ruiz, M., Baena, J. M., Vicente, D., Pineda, M. D.

“…Abstract only…”
Get full text

Multiagent home telecare platform for patients with cardiac diseases by Traver, V., Monton, E., Bayo, J.L., Garcia, J.M., Hernandez, J., Guillen, S.

“…Paper presents a home telecare platform for patients with cardiac diseases usable by medical staff or patients through several agents: a personal digital…”
Get full text

Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy by Manso, L, Ciruelos, E, Codes, M, De la Haba, J, Galan, A, Baena, J, Jaen, A, Gil, M, Murias, A, Blancas, I, Gonzalez, E, Perez, D, Bayo, JL, Mel, J, Garcia-Martinez, E, Cubedo, R, Salvador, J

Get full text

P5-14-22: Prospective Observational Study To Describe the Clinicopathological and Biological Characteristics and the Management of Metastatic Breast Cancer Patients Who Experienced Complete or Partial Remission or Disease Stabilization during at Least 3 Years by Zamora, P, Pérez-Carrión, R, Manso, L, Crespo, C, Mendiola, C, Alvarez-López, I, Margeli, M, Bayo-Calero, JL, González-Farre, X, Santaballa, A, Ciruelos, EM, Afonso, R, Lao, J, Catalán, G, Alvarez-Gallego, JV, Miramón-López, J, Salvador-Bofill, FJ, Ruiz-Borrego, M

“…Background Trastuzumab has shown an improvement in survival outcomes among patients with HER2+ metastatic breast cancer (MBC). Identification of pathological,…”
Get full text

Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: Preliminary results from a phase II trial by Pelegrı́, Amadeu, Calvo, Lourdes, Mayordomo, José I, Florián, Jesús, Vázquez, Santiago, Arcusa, Angels, Martı́n-Richard, Marta, Bayo, José L, Virizuela, Javier, Carrasco, Eva, Antón, Antonio

“…The purpose of this study was to assess the toxicity and efficacy of gemcitabine and docetaxel administered every other week as first-line therapy in…”
Get full text